Category: Corporate

Categories
Corporate

Sensex falls 455 points, Nifty slips below 24,600

Markets ended sharply lower on Friday, as pressure on financial stocks outweighed gains in information technology, automobiles and selected heavyweight shares. The benchmark BSE Sensex fell 455.65 points, or 0.58%, to close at 78,499.17, while the Nifty 50 declined 65.35 points, or 0.27%, to settle at 24,570.65.

The session remained volatile as investors adjusted to the newly introduced Closing Auction Session (CAS), which entered its fifth day. The new mechanism continued to create some divergence between the closing movements of the Sensex and Nifty. Market participants, however, expect this volatility to ease as traders and institutions become more familiar with the process.

On the Nifty 50, TCS, Mahindra & Mahindra and ONGC were among the leading gainers during the session. TCS emerged as a strong performer as IT stocks found buying interest. Grasim Industries and State Bank of India also traded firmly, with SBI gaining around 1.1% by the close.

At the other end, Bajaj Finance, Bajaj Finserv and Trent were among the biggest losers. Bajaj Finance ended down about 5.8%, while Bajaj Finserv declined around 3.7%. Trent also fell more than 3.5%, with ICICI Bank and other financial stocks adding to the pressure on the benchmark.

The sharp fall in Bajaj Finance and Bajaj Finserv came after a new Reserve Bank of India proposal concerning non-banking financial companies. The proposed framework would restrict NBFCs from offering revolving credit products, except for entities authorised to issue credit cards. Investors interpreted the proposal as potentially affecting the business models of some large consumer lenders, triggering selling in the sector.

Financial stocks therefore became the main drag on the market. Financial Services, banking and private-bank indices ended in the red, while IT emerged as the strongest sectoral performer, gaining around 2%. Auto stocks also remained relatively resilient, with realty, FMCG and healthcare stocks seeing selective buying.

The broader market showed a somewhat different picture. While the Nifty Smallcap 100 ended lower, the Nifty Midcap 100 gained about 0.2%. This suggested that selling pressure was concentrated more heavily in large financial stocks rather than being spread uniformly across the market.

Several individual stocks also reacted sharply to quarterly earnings. Hero MotoCorp rose more than 3% after reporting a 29% year-on-year increase in standalone net profit to ₹1,454 crore for the June quarter. Revenue increased 36% to ₹12,999 crore, helping the two-wheeler major beat market expectations.

Titan Company also reported strong first-quarter numbers. Its profit rose 65% year-on-year to ₹1,699 crore, while revenue increased 24% to ₹18,101 crore. The results provided some support to the consumer-facing segment even as the broader market remained under pressure.

In contrast, Godrej Consumer Products slipped more than 4% despite reporting a 12% increase in consolidated net profit to ₹505 crore. Investors focused on pressure on margins amid higher commodity costs. Ixigo also fell sharply, declining as much as 9.4%, despite reporting its highest-ever quarterly profit, highlighting how investors are increasingly looking beyond headline earnings to assess future spending and profitability.

The solar-energy space also remained under pressure. Vikram Solar dropped around 11% to a fresh lifetime low after reporting an 85% year-on-year decline in first-quarter profit. Concerns about margins and the impact of a US tariff on polysilicon products added to investor worries around the sector.

Meanwhile, commodity markets were firmer. Aluminium futures rose 1.07% to ₹352.95 per kg, zinc futures gained 0.49% to ₹396.80 per kg, and copper futures climbed 0.77% to ₹1,386.55 per kg, supported by fresh positions and firm spot demand.

The rupee remained broadly stable, ending at ₹95.2075 against the US dollar, compared with ₹95.22 in the previous session.

Global cues remained mixed. US equity futures were modestly positive during Indian trading hours, while European markets also traded higher. However, investors remained cautious ahead of US payroll data, which could influence expectations around the Federal Reserve’s interest-rate path and global fund flows.

Crude oil remained another concern. Prices moved above $83 a barrel amid renewed uncertainty surrounding the Strait of Hormuz and geopolitical developments involving Iran. Higher oil prices can add pressure to India’s import bill, inflation outlook and corporate margins.

Despite Friday’s decline, the domestic market retained part of its weekly gains. The Nifty 50 finished the week about 0.8% higher, while the Sensex gained roughly 0.5%. Foreign investors have also remained supportive, with foreign portfolio investors putting about $1.3 billion into Indian equities in August after investing $2.1 billion in July.

For investors, the week’s trading offered a clear reminder that the market is being driven by several forces at once — quarterly earnings, regulatory changes, crude oil prices, global cues and the transition to the new closing mechanism. While sectors such as IT, auto and telecom continue to show earnings resilience, elevated valuations could limit the market’s upside, according to market strategist VK Vijayakumar of Geojit Investments.

With the CAS still settling into the Indian market structure, traders are likely to watch closing-price volatility closely in the coming sessions. For now, the focus remains on earnings, financial-sector regulation, crude prices and global economic data as Dalal Street heads into the next week.

Categories
Corporate

Sensex tumbles 400 points, Nifty breaks below 24,600

Indian equity markets came under pressure on Friday as the Sensex fell more than 400 points and the Nifty 50 slipped below the 24,600 mark. Rising crude oil prices, renewed concerns over the Strait of Hormuz and selling in financial stocks kept investors cautious, even as gains in select automobile, consumer and technology stocks offered some relief.

The Sensex opened on a weak note and extended its losses during the morning session, while the Nifty also struggled to hold key levels. At around 11:38 am, the Nifty 50 was trading at 24,578.75, down 57.25 points. The market remained volatile as investors assessed global developments alongside the latest corporate earnings.

Financial stocks were among the biggest drags on the benchmarks. Bajaj Finance and Bajaj Finserv emerged among the top losers, falling sharply after the Reserve Bank of India proposed new regulatory norms for non-banking financial companies. Bajaj Finance declined around 3.9%, while Bajaj Finserv was down about 3.3% during the session.

The proposed RBI framework has raised concerns over tighter rules for certain lending products and business practices. The selling in the two stocks also weighed on the broader financial services space, which remained one of the weakest segments of the market.

In contrast, Hero MotoCorp and Britannia Industries were among the top gainers. Hero MotoCorp rose around 3% after the company reported a strong first-quarter performance. Its consolidated profit increased 29% year-on-year, supported by higher revenue and improved operating performance.

Britannia Industries also attracted buying interest after reporting a healthy quarterly performance. The stock gained nearly 4%, helping the consumer segment remain relatively resilient despite the broader market weakness.

Kalyan Jewellers was another stock in focus, gaining around 3.7% after positive commentary from brokerage Jefferies. The movement showed that investors continued to favour companies with strong earnings prospects or favourable analyst views, even as the broader market remained under pressure.

The biggest concern for the market, however, was the renewed rise in crude oil prices. Brent crude moved above $84 a barrel amid heightened concerns about shipping through the Strait of Hormuz. The waterway is a crucial route for global oil shipments, and any prolonged disruption could push energy prices higher.

Higher crude prices are particularly important for India because the country relies heavily on imported oil. A sustained increase in energy costs could widen the import bill, put pressure on the rupee and complicate the inflation outlook. It could also affect the profitability of companies that are unable to pass higher input costs on to consumers.

The rise in oil prices came alongside fresh geopolitical concerns involving Iran and the wider Middle East. Investors are therefore closely monitoring developments around the Strait of Hormuz for signs of a prolonged disruption or further escalation.

The India VIX, which tracks expected volatility in the equity market, also moved higher during the session. The increase indicated growing caution among traders and suggested that investors were preparing for larger swings in stock prices.

Despite the weakness in the headline indices, the market was not uniformly negative. Information technology stocks remained among the better-performing sectors, while automobile, healthcare and realty stocks also found buying interest. This helped limit the overall damage from the sell-off in financial shares.

Among individual stocks, Siemens Energy India was one of the notable performers after its quarterly results. Indraprastha Medical Corporation also advanced following its earnings announcement. These gains highlighted how company-specific developments continued to influence trading despite the broader risk-off mood.

At the other end of the spectrum, Vikram Solar plunged around 11%, touching a fresh lifetime low. The sharp decline added to the volatility in individual stocks and reflected the heightened sensitivity towards companies facing concerns around valuations or business performance.

Investors are also keeping a close watch on the ongoing Q1 earnings season. Several companies have delivered strong revenue and profit growth, providing support to the market. However, expensive valuations, elevated crude prices and uncertainty over global interest rates have made investors more selective.

Global cues also remained mixed. Asian markets traded without a clear direction, while US stocks had closed lower in the previous session. Investors were awaiting fresh US economic data for clues about the Federal Reserve’s future interest-rate decisions.

For the Indian market, the immediate focus is likely to remain on crude oil prices, geopolitical developments, foreign fund flows and corporate earnings. The movement of the Nifty around the 24,600 level will also remain important for traders in the near term.

Friday’s session once again showed the contrasting forces shaping Indian equities. Strong earnings and buying in select stocks are providing support, but financial-sector weakness, rising oil prices and geopolitical uncertainty are keeping the benchmark indices under pressure.

Categories
Corporate

Aurobindo Pharma Q1 profit jumps 25% to ₹1,032 cr

Aurobindo Pharma has started the new financial year on a strong note, reporting a 25.2% year-on-year rise in consolidated net profit to ₹1,032 crore for the April-June quarter. The Hyderabad-based drugmaker also posted its highest-ever quarterly revenue, helped by broad-based growth across the US, Europe and other international markets.

Revenue from operations increased 16.3% year-on-year to ₹9,150 crore in Q1 FY27, compared with ₹7,870 crore in the same quarter last year. The company said the quarter benefited from higher volumes, new product launches and stronger performance across its formulations business.

The numbers underline a healthy start for Aurobindo Pharma, particularly as the company continues to expand its global generics portfolio and strengthen its presence in key overseas markets.

Europe emerged as one of the strongest contributors during the quarter. Revenue from the European business jumped 25.6% to ₹2,937 crore from the year-ago period. The company reported broad-based growth across major European markets.

The US business, which remains an important part of Aurobindo Pharma’s international operations, also performed well. Revenue from the US increased 8.1% year-on-year to ₹3,770 crore. The growth was supported by higher volumes and new product launches.

The company’s Growth Markets business delivered an even sharper increase. Revenue from these markets rose 37.7% to ₹1,063 crore, reflecting stronger demand across markets outside its major US and European operations.

The performance shows that Aurobindo is not depending on a single geography for growth. Its diversified international presence is helping the company manage changing conditions in individual markets.

The formulations business, which contributes the largest share of Aurobindo Pharma’s revenue, grew 16.5% year-on-year to ₹8,101 crore during the quarter.

The company said growth in US formulations was supported by new product launches and higher volumes. Europe also delivered strong growth across several markets.

The active pharmaceutical ingredients (API) business was another positive contributor. API revenue increased 14.6% to ₹1,049 crore during Q1 FY27.

Aurobindo also received final US Food and Drug Administration approvals for 10 products during the quarter and launched 10 products in the US market. New product launches are particularly important for generic drugmakers because they can help companies build revenue as older products face pricing pressure and competition.

Aurobindo’s operating performance also improved during the quarter. Operating EBITDA, excluding forex impact and other income, rose 20% year-on-year to ₹1,924 crore.

The corresponding EBITDA margin expanded by 60 basis points to 21%. This indicates that the company was able to convert a part of its revenue growth into stronger operating profitability.

The improvement is notable because pharmaceutical companies continue to operate in a competitive global environment, where pricing pressure, regulatory requirements and currency movements can affect margins.

Aurobindo Vice Chairman and Managing Director K. Nithyananda Reddy said the company had begun FY27 with healthy growth across businesses, supported by disciplined execution, operational performance and a diversified product portfolio. He also acknowledged that the global operating environment remains dynamic.

Alongside the quarterly results, Aurobindo Pharma announced a significant corporate restructuring involving its injectable medicines business.

The company’s board approved a proposal to merge Eugia Steriles Private Limited and Eugia SEZ Private Limited with wholly owned subsidiary Eugia Pharma Specialities Limited. The proposal will require approval from the National Company Law Tribunal (NCLT).

All three companies are involved in the manufacture of injectable pharmaceutical products. The proposed amalgamation is aimed at bringing similar operations under one legal entity and simplifying the group’s corporate structure.

Aurobindo expects the restructuring to remove overlapping corporate and administrative functions, reduce costs, improve treasury management and create operational synergies. The company said the merger will not change its shareholding structure and will not involve any cash consideration because the entities are wholly owned within the group.

The move is part of Aurobindo’s broader effort to make its business structure more efficient as it expands its specialty and injectable drug operations.

The June quarter also included the completion of Aurobindo’s acquisition of Lannett Company LLC in the US. The transaction was completed on June 29.

Aurobindo said it ended the quarter with a net cash position of $42 million, or about ₹397 crore, including investments. This was despite spending $247 million on the Lannett acquisition and $85 million on a share buyback.

The Lannett acquisition strengthens Aurobindo’s US generics presence and adds to its product and operational capabilities in the world’s largest pharmaceutical market.

The company is also continuing to build its international footprint. During the quarter, it incorporated new step-down subsidiaries in France and Indonesia. It also acquired a 26% stake in Swarnaakshu Solar Power Private Limited.

After the quarter ended, Aurobindo subsidiary Apitoria Pharma approved the acquisition of an 80% interest in the A1 Biochem Group for an enterprise value of $17 million.

For investors tracking Aurobindo Pharma shares, the latest results provide several positives, including record quarterly revenue, double-digit growth across major markets, improving operating margins and a strong product pipeline.

At the same time, the company operates in a highly regulated and competitive global pharmaceutical market. US pricing, regulatory approvals, product launches, currency movements and the integration of recent acquisitions will remain important factors for future performance.

For now, however, the June quarter has given Aurobindo Pharma a solid beginning to FY27. Strong growth in Europe and Growth Markets, steady expansion in the US and improving profitability suggest that the company’s international strategy is gaining momentum.

The planned Eugia merger adds another layer to the story by simplifying the corporate structure and potentially reducing duplication. With new products, acquisitions and restructuring happening alongside organic growth, Aurobindo is entering FY27 with a broader platform for expansion.

Categories
Corporate

LIC OFS sees strong demand, subscription hits 2.27x

The government’s offer for sale (OFS) in Life Insurance Corporation of India (LIC) received a strong response from investors, with the issue getting subscribed more than twice by the time bidding closed on Wednesday. The Centre ultimately sold 82.22 crore shares, representing a 6.5% stake in the country’s largest insurance company.

The LIC OFS helped the government raise around ₹31,552 crore, making it one of the biggest equity stake sales in India. Strong demand, particularly from institutional investors, allowed the government to exercise the greenshoe option and expand the size of the transaction beyond the initial 2.5% stake on offer.

The final offering included a base issue of around 31.62 crore shares and an additional 50.59 crore shares through the oversubscription or greenshoe option. Overall, investors placed bids for about 187.15 crore shares, resulting in subscription of roughly 2.27 times the shares offered.

The government had fixed the floor price for the LIC OFS at ₹382 per share. This represented a significant discount to LIC’s market price before the stake sale was announced and was intended to make the offering attractive to investors.

The non-retail category received particularly strong interest. The segment, which covered about 74 crore shares, received bids for nearly 129.48 crore shares and was subscribed around 1.57 times based on the initial clearing calculations. The final allotment price was subsequently fixed at ₹383.69 per share, slightly above the floor price.

Retail investors, however, showed a more cautious response. The retail portion consisted of about 8.22 crore shares, against which bids were received for around 5.76 crore shares. This translated into subscription of roughly 70%. Retail investors were offered an additional discount, with the applicable price set ₹10 below the non-retail clearing price.

The contrasting response from institutional and retail investors highlights an important feature of the LIC share sale. While large investors appeared comfortable taking exposure to the stock at a discounted valuation, individual investors were more measured, even with the additional price benefit.

The OFS was initially planned as a sale of 2.5% of LIC by the government. However, the Centre had retained the option to sell another 4% through the greenshoe mechanism if demand was strong. The government eventually used the option in full, taking the total stake sold to 6.5%.

The transaction also has a larger significance for LIC’s shareholding structure. Before the OFS, the government owned around 96.5% of the insurer. Following the sale, its holding has come down to about 90%, while public shareholding in LIC has risen to 10%. This meets an important minimum public shareholding milestone ahead of schedule.

For the government, the LIC OFS is not merely a fund-raising exercise. It is also part of its broader disinvestment and asset-monetisation strategy. The successful completion of the transaction gives the Centre greater flexibility in managing its remaining stake in LIC while increasing the proportion of shares available to public investors.

LIC’s journey in the capital market began with its blockbuster initial public offering in May 2022. The ₹20,500-crore IPO was the largest public issue in India at the time. The government had sold a 3.5% stake through that IPO, although the original plan had been to dilute a larger portion.

The latest OFS therefore marks another major step in the government’s efforts to broaden LIC’s public ownership. It also increases the stock’s free float, potentially improving liquidity and participation in the market over time.

For LIC, the stake sale comes at a time when investors are closely watching the insurer’s financial performance, growth prospects and ability to compete in an increasingly competitive insurance market. The company remains one of India’s most recognisable financial brands, with a vast customer base and a dominant position in the life insurance sector.

The immediate market reaction, however, could remain sensitive to the additional supply of LIC shares entering the public market. A large OFS can create short-term pressure on a stock as investors adjust to the increased supply. LIC shares had already come under pressure after the government announced the discounted stake sale.

At the same time, the strong institutional participation provides a measure of confidence in the offering. The government’s ability to sell the full 6.5% stake and raise more than ₹31,500 crore indicates that investors were willing to absorb a substantial block of LIC shares at the offered valuation.

 

Categories
Corporate

Sensex rises 370 points, Nifty ends above 24,600

Indian equity markets ended higher on Thursday, August 6, as the Sensex gained 374 points, or 0.48%, to close at 78,785, while the Nifty 50 rose 0.05% to settle at 24,636. The Nifty managed to stay above the closely watched 24,600 level, although the market remained largely range-bound through the session.

The broader market showed a mixed trend. The Nifty Midcap 100 fell 0.44%, while the Nifty Smallcap 100 gained 0.48%, indicating that investors continued to favour select stocks rather than make broad-based bets.

Among individual stocks, Navin Fluorine International emerged as one of the day’s strongest performers. The stock jumped 13.3% after the specialty chemicals company reported better-than-expected June-quarter earnings.

Neuland Laboratories was another major gainer, rising 8.2%, also helped by its strong quarterly performance. Investors responded positively to the companies’ earnings, showing once again how quarterly results can drive stock-specific moves even when the broader market is subdued.

Tata Technologies also made a strong comeback after two consecutive sessions of losses. Its shares climbed 6.3% to ₹801, giving the stock a much-needed recovery during Thursday’s trading session.

Defence stocks were another bright spot. Mazagon Dock Shipbuilders gained 6.3% to ₹2,530, while Hindustan Aeronautics, ideaForge Technology, MTAR Technologies, TechEra Engineering, Bharat Dynamics, Garden Reach Shipbuilders & Engineers and Zen Technologies each advanced more than 3%.

Other notable gainers included Finolex Cables, Apar Industries, Tata Capital, JM Financial, Aditya Infotech, State Bank of India, Indian Bank, Chalet Hotels, Biocon, Rail Vikas Nigam and Gland Pharma, which rose more than 2.5% each.

On the other side, Firstsource Solutions was the biggest loser among the stocks tracked by Mint, plunging 13.4% to ₹294. The sharp fall weighed on the stock after its recent performance and came amid selling pressure across select counters.

Blue Star, Saregama India and Cemindia Projects also faced heavy selling, with each stock declining more than 4%.

HFCL slipped 4% to ₹203 as investors booked profits following its recent rally. The movement was a reminder that stocks that rise sharply over a short period can face selling when traders choose to lock in gains.

Bikaji Foods International also declined 4% to ₹624. Other notable losers included Power Grid Corporation, Great Eastern Shipping, Go Digit General Insurance, Gabriel India, Blue Dart Express, Lodha Developers and BSE, all of which fell more than 3%.

The broader market remained focused on developments in West Asia, particularly the possibility of a diplomatic agreement involving Iran and Oman.

Reports suggested that Iran had moved closer to an agreement with Oman on reopening the Strait of Hormuz, a critical route for global oil shipments. US officials have also indicated that negotiations with Iran could be nearing a deal.

For Indian investors, this development is important because any disruption in the Strait of Hormuz can have a direct impact on crude oil supplies and prices. India imports a substantial portion of its crude requirement, making oil prices a key factor for the country’s inflation, current account balance and corporate profitability.

Crude oil prices stabilised on Thursday after declining for three consecutive sessions. The improvement in diplomatic prospects helped ease fears of a prolonged supply disruption.

Lower crude prices are generally positive for Indian equities. They can reduce the country’s import bill and ease pressure on the rupee. Companies in sectors such as aviation, paints, chemicals and logistics can also benefit when fuel and input costs remain under control.

The sectoral performance reflected the cautious mood. Nifty PSU Bank, Chemicals, Oil & Gas and Consumer Durables witnessed buying interest, while Realty, Media, Auto and Metal stocks ended lower.

The mixed performance showed that investors were still selective. Rather than chasing the broader market, traders appeared more comfortable with companies showing strong earnings or those benefiting from specific sectoral developments.

The market also had to contend with weekly expiry-related volatility. According to brokerage firm Lemonn, buying near important support levels helped the Nifty recover from its intraday lows, while selective gains across some sectors helped offset weakness in banking and IT stocks.

The Nifty’s ability to remain above 24,600 will remain important in the near term. A sustained recovery above this level could improve sentiment, while a failure to hold it could bring renewed selling pressure.

Investors will also closely track crude oil prices, developments in the US-Iran negotiations and corporate earnings for further direction.

Thursday’s session showed that the Indian stock market is still being driven by a delicate balance of domestic earnings and global geopolitical developments. The Sensex managed a meaningful 374-point recovery, but the nearly flat Nifty showed that investors remain unwilling to take aggressive positions.

For now, the market’s message is fairly clear: investors are ready to buy, but only when they see a reason. Strong quarterly results lifted stocks such as Navin Fluorine, Neuland Laboratories and Tata Technologies, while profit booking and weak sentiment dragged down Firstsource Solutions, HFCL and Bikaji Foods.

With crude oil prices easing and hopes of progress on the US-Iran front improving, the immediate pressure on Indian equities has reduced. However, investors are likely to remain cautious until there is greater clarity on whether the diplomatic efforts can deliver a lasting resolution.

The next few trading sessions could therefore be crucial for determining whether the Nifty can build on its support above 24,600 or slip back into a period of consolidation.

Categories
Corporate

MV Electrosystems shares make strong 22% market debut

MV Electrosystems made a strong debut on the stock market on Thursday, August 6, giving investors who received shares in its initial public offering (IPO) an immediate gain of more than 22%. The railway electrical and power electronics company listed its shares at ₹520 apiece on the National Stock Exchange (NSE), compared with its IPO issue price of ₹425.

The NSE listing represented a 22.35% premium over the issue price. On the BSE, the shares opened at ₹519, translating into a 22.12% gain. The stock then attracted further buying interest during the session, rising as high as ₹586 on the BSE, or about 37.9% above the IPO price.

The strong market debut came after an exceptionally strong response to the MV Electrosystems IPO. The ₹290-crore public issue was subscribed 188.85 times by the time bidding closed on August 3. Investors placed bids for more than 753 million shares against about 3.99 million shares available for subscription, according to exchange data.

The enthusiasm was visible across investor categories. The qualified institutional buyers’ (QIB) portion was subscribed 90.47 times, while the non-institutional investor category saw subscription of 374.58 times. Retail investors also showed strong interest, with their portion subscribed 205.42 times.

For retail investors who secured one lot, the listing translated into a sizeable paper gain. The IPO lot consisted of 34 shares, requiring an investment of ₹14,450 at the upper end of the price band. At the NSE listing price of ₹520, that investment was worth ₹17,680, giving an immediate gain of ₹3,230 per lot.

The IPO had a price band of ₹400 to ₹425 per share and consisted entirely of a fresh issue. There was no offer-for-sale (OFS) component, meaning the entire ₹290 crore raised was intended to go into the company rather than provide an exit for existing shareholders.

According to the company’s offer documents, the funds are intended to support long-term working capital requirements, research, design and development of new power electronics equipment and general corporate purposes. The fresh capital could therefore help MV Electrosystems expand its operations as demand grows across India’s railway and infrastructure sectors.

MV Electrosystems operates in a specialised segment of the railway industry. The Mumbai-based company designs, develops, assembles and manufactures electrical and power electronics equipment used in railway rolling stock. Its product portfolio includes propulsion systems for electric locomotives, switchgear panels and other railway electrical components.

One of the factors attracting investor attention is the company’s exposure to India’s railway modernisation and electrification programme. Analysts have pointed to its position in areas such as railway electrification, propulsion systems, power electronics and industrial automation as potential long-term growth drivers.

Before the listing, analysts had also highlighted the company’s order book. MV Electrosystems had an order book of ₹921.64 crore as of June 30, 2026, providing visibility for future revenue, according to Mint’s report. The company’s presence in specialised railway equipment could allow it to benefit from continued spending on railway infrastructure and electrification.

The IPO had also attracted ₹130.5 crore from anchor investors ahead of the public issue. The anchor allocation included several institutional investors and investment funds, adding to the confidence surrounding the offering.

Interestingly, the stock’s actual debut was somewhat more conservative than the expectations built up in the grey market. Before listing, the IPO’s grey market premium (GMP) had indicated an estimated listing price of around ₹534, implying a premium of nearly 26% over the issue price. The actual NSE listing at ₹520 was therefore slightly below that expectation, but it still delivered a healthy opening gain.

The listing also highlights the difference between IPO excitement and long-term investment performance. A heavily subscribed IPO can create strong demand when trading begins, but the initial listing premium does not automatically guarantee sustained gains. Analysts have advised investors to look beyond the first-day movement and track earnings, order execution, margins and future growth.

For investors who received an allotment, the sharp opening gain offered an opportunity to lock in profits. At the same time, those considering buying MV Electrosystems shares after listing may need to assess whether the company’s fundamentals justify the higher market valuation following the strong debut.

By the time of the initial trading session, MV Electrosystems had reached a market valuation of around ₹1,588.67 crore, according to PTI data reported by Rediff.

Overall, MV Electrosystems’ stock market debut has given India’s IPO market another closely watched listing. The combination of a 188.85-times subscription, strong institutional and retail participation, a ₹290-crore fresh issue and a 22% listing premium reflects the high investor appetite for companies linked to railway infrastructure and specialised engineering.

The bigger test, however, begins after the debut. Investors will now watch whether MV Electrosystems can convert its strong order book and sector opportunity into sustained revenue growth and profitability.

Categories
Corporate

Sensex gains over 250 points, Nifty holds above 24,650

Equity markets traded higher on Thursday, with the benchmark Sensex gaining more than 250 points and the Nifty 50 holding above the 24,650 mark. Investors found some comfort in a better-than-expected June-quarter earnings season and hopes of a diplomatic resolution to the Middle East crisis, although the overall market remained selective.

The market’s tone was helped by buying in banking, pharmaceuticals, healthcare, chemicals, real estate and oil and gas stocks. Select midcap shares also attracted interest. At the same time, investors remained cautious in auto, IT, media, metal, private banking, FMCG and cement stocks, keeping the broader market from turning uniformly bullish.

Among the prominent gainers, HCL Technologies and ICICI Bank were among the early leaders in the Sensex pack. Their gains helped the benchmark index stay firmly in positive territory.

Outside the frontline indices, Hindustan Aeronautics Ltd (HAL) was one of the standout performers. Its shares jumped more than 6% for a second consecutive session after the company’s annual report highlighted a strong FY26 order book of around Rs 2.55 lakh crore. The order pipeline provides the defence major with revenue visibility for the next seven to eight years. The company is also looking to accelerate production by improving its supply chain, expanding capacity and investing in infrastructure.

Navin Fluorine International was another major mover, with the stock surging around 11% after its June-quarter profit more than doubled. The strong earnings performance renewed buying interest in the specialty chemicals company. Neuland Laboratories also gained more than 6% after reporting a 975% year-on-year jump in first-quarter profit, making both stocks prominent among the day’s earnings-driven movers.

PB Fintech, the parent company of Policybazaar, also remained in focus. Its shares rose around 2% after the company reported a 92% year-on-year increase in Q1 FY27 net profit to Rs 163 crore. The growth was supported by higher insurance premiums, stronger operating revenue and improved margins. However, analysts remained cautious about the stock’s valuation, with Morgan Stanley and Nomura seeing significant downside risks.

Sterlite Technologies gained around 4% after announcing an international order worth Rs 1,760 crore, adding another stock-specific trigger to the session. Meanwhile, newly listed Juniper Green Energy made its market debut at a 9% premium over its IPO price, giving investors another point of interest in the primary-market segment.

The broader market, however, did not show the same strength as the headline indices. Nine of the 16 Nifty sectoral indices were reported to be lower, reflecting a mixed investment mood. The divergence suggests that investors are still rotating between sectors and individual stocks rather than making broad-based bets.

Global cues also remained mixed. S&P 500 futures edged higher, while Japan’s Topix declined. Australia’s benchmark gained, whereas Hong Kong’s Hang Seng fell sharply. The Shanghai Composite and Euro Stoxx futures were marginally positive. The mixed overseas signals meant that domestic earnings and company-specific developments continued to play a major role in determining the direction of Indian stocks.

Market participants are also keeping a close eye on the weekly derivatives expiry, which could lead to increased volatility during the later part of the session. The market is adjusting to changes linked to the Closing Auction Session, which had contributed to sharp swings in the previous session. The India VIX had declined 1.5% to 12 on Wednesday, suggesting that some immediate anxiety had eased.

From a technical perspective, the 24,650 level is important for the Nifty 50. Geojit Investments’ Chief Market Strategist Anand James said a sustained move above 24,650 could be an early indication of a potential breakout, while 24,550 was identified as the day’s downside marker. The next important hurdle is around 24,775.

Investors are therefore balancing optimism over corporate earnings with concerns around valuations, global uncertainty and foreign fund flows. The latest market action suggests that buyers are returning, but they remain selective.

For now, the focus remains on whether the Sensex and Nifty can hold their gains and whether the Nifty can move decisively beyond 24,650. A sustained breakout could improve sentiment further, while failure to hold the level may bring back profit-taking.

Foreign institutional investor activity, crude oil prices and the rupee’s movement against the dollar will also remain important triggers, as traders assess the sustainability of the current market recovery.

Categories
Corporate

Manipal Health shares rise 11% in market debut

Manipal Health Enterprises made a positive debut on the Indian stock exchanges on Wednesday, with shares listing at a premium of around 11% over the initial public offering (IPO) price. The strong opening reflects investor interest in one of India’s largest private hospital networks, even as concerns remain about its rich valuation and debt levels.

The Manipal Health share price opened at ₹652 on the National Stock Exchange (NSE), a 10.5% premium to its issue price of ₹590. On the Bombay Stock Exchange (BSE), the stock began trading at ₹655, gaining 11.01%. The shares later touched ₹653.10 on the NSE, taking the company’s market value to about $9 billion.

The market debut came after Manipal Health raised ₹9,275.22 crore through its IPO, making it one of India’s biggest public offerings of 2026. The issue was the country’s second-largest IPO of the year, behind SBI Funds Management. The offering attracted strong institutional demand despite relatively cautious participation from retail investors.

The IPO was open for subscription between July 29 and July 31. It was subscribed 4.92 times overall, with investors bidding for more than 443 million shares against around 90 million shares available after adjustments for anchor investors. Qualified institutional buyers showed the strongest interest, with their portion subscribed 8.25 times. The non-institutional investor category was subscribed 1.02 times, while the retail portion was subscribed 0.93 times.

The difference between institutional and retail demand was partly linked to concerns over Manipal Health’s valuation. At the upper end of its IPO price band, the company was valued at about 84.65 times its projected fiscal 2026 earnings. That was higher than the valuations of major listed hospital companies such as Apollo Hospitals, Fortis Healthcare and Max Healthcare, which were trading at lower earnings multiples.

Still, investors appear willing to pay a premium for Manipal Health’s scale and long-term growth prospects. Backed by Singapore state investment firm Temasek, the company has built a large pan-India healthcare network. It operates 49 hospitals with more than 13,000 beds, making it India’s largest multispecialty hospital network by bed capacity.

The company’s growth has been driven by both expansion and acquisitions. Its network now covers a large part of India’s organised private healthcare market, giving it a presence across multiple cities and regions. This footprint could help Manipal Health benefit from rising demand for specialised medical services as India’s population ages and lifestyle-related and chronic diseases become more common.

The hospital sector has also been attracting increasing attention from global investors. Large investment firms have been putting money into India’s healthcare market, encouraged by rising healthcare spending, greater demand for quality treatment and opportunities to consolidate a fragmented hospital industry. Manipal Health’s listing therefore comes at a time when the broader Indian healthcare sector is attracting strong domestic and international interest.

However, the company’s rapid expansion has also resulted in significant borrowing. A major purpose of the IPO was to strengthen its balance sheet. Manipal Health plans to use a substantial portion of the funds raised to repay or prepay borrowings at its subsidiary, Manipal Hospitals.

The company also intends to use part of the IPO proceeds to acquire a minority stake in Sahyadri Hospitals. The move would strengthen its position in the Indian hospital market while supporting its strategy of expanding through acquisitions and increasing its presence in important healthcare markets.

Manipal Health is not stopping with its current network. The company plans to invest around ₹4,000 crore to expand its bed capacity by more than 18%. The expansion is expected to add about 2,400 beds over the next three to four years. If implemented as planned, the additional capacity could support revenue growth while allowing the hospital chain to serve more patients.

The company’s growth plans put it in direct competition with established listed hospital chains. Apollo Hospitals, Max Healthcare and Fortis Healthcare are among the key players investors will compare Manipal Health with after its listing. Apollo, for instance, currently has nearly 10,000 beds and has set its own target of reaching around 13,000 beds by fiscal 2030.

For investors, the key issue now is whether Manipal Health can maintain its earnings growth quickly enough to support its premium valuation. A strong listing provides an encouraging start, but the company will have to demonstrate that its expansion strategy can translate into sustainable profits, lower debt and stronger cash generation.

The company’s stock market debut nevertheless marks an important milestone for India’s healthcare industry. With more than 13,000 beds, a nationwide network and plans for further expansion, Manipal Health has entered the listed market with considerable scale.

The immediate 11% listing gain shows that investors are confident about the long-term healthcare opportunity in India. But sustaining that confidence will depend on execution. For Manipal Health, the next phase will be about balancing expansion with financial discipline and proving that its growing hospital network can deliver consistent returns to shareholders.

Categories
Corporate

L&T bags ₹15,000 cr ADNOC offshore contract

Larsen & Toubro (L&T) has won an ultra-mega offshore contract worth more than ₹15,000 crore from ADNOC Offshore in the United Arab Emirates, marking another major breakthrough for the Indian engineering and construction company in the Middle East.

The order has been secured by L&T Energy Hydrocarbon Offshore (LTEH Offshore), which will execute the project as the lead member of a consortium. The contract covers a wide range of activities, including engineering, procurement, construction, installation and commissioning.

L&T has classified the contract as an “ultra-mega” order, a category reserved for projects valued above ₹15,000 crore. The company has not disclosed the exact value of the award.

The project involves the development of offshore facilities along with modifications and upgrades to existing infrastructure. L&T will be responsible for a substantial portion of the project execution, giving its offshore hydrocarbon business another sizeable assignment in the Gulf region.

A key component of the contract will be fabrication work. A significant share of the fabrication is expected to be carried out at L&T’s dedicated facilities before the structures and equipment are transported for offshore installation. This will allow the company to use its integrated engineering and fabrication capabilities throughout the project.

The latest order further strengthens L&T’s long-standing relationship with ADNOC Offshore, the offshore exploration and production arm of Abu Dhabi National Oil Company. L&T has previously delivered several major projects for energy companies in the Middle East, making the region an important market for its hydrocarbon business.

The contract comes as the UAE continues to invest in its oil and gas infrastructure. Despite the global shift towards renewable energy and cleaner fuels, hydrocarbons remain a major part of the Gulf economy. Existing offshore fields require continuous expansion, maintenance and modernisation to maintain production capacity and improve operational efficiency.

For L&T, the new project provides greater visibility for its international order book. Large EPC contracts are typically executed over multiple years, providing companies with a steady pipeline of engineering, construction and commissioning work.

The award also highlights the growing international reach of L&T’s energy business. The company has developed capabilities covering the entire offshore project cycle, from front-end engineering and procurement to fabrication, transportation, installation and commissioning.

Offshore oil and gas projects are among the most technically demanding assignments in the engineering sector. They require specialised equipment, extensive project planning, strict safety standards and the ability to coordinate activities across onshore fabrication yards and offshore locations.

L&T’s experience in handling such complex projects has helped it build a strong presence in the international EPC market. Its fabrication facilities and marine capabilities allow the company to manage large offshore structures and equipment before they are installed at sea.

The ADNOC order is also expected to support L&T’s broader strategy of expanding its presence in international markets. While India remains a key market for the company across infrastructure, technology and energy, overseas projects provide geographical diversification and access to large-scale investment opportunities.

The Middle East has emerged as a particularly important market for Indian engineering companies. Governments and energy producers across the region are continuing to invest in infrastructure, oil and gas production, petrochemicals and newer energy technologies. L&T’s established presence gives it an advantage when competing for these projects.

The company’s latest win also comes at a time when investors are closely tracking its order inflows. A strong order book is important for L&T because it provides visibility into future revenue and supports long-term growth. However, the eventual financial benefit will depend on project execution, costs, timelines and margins.

L&T shares responded positively to the announcement, gaining during trading after the company disclosed the contract. The market reaction reflected investor interest in the size of the order and its potential contribution to the company’s future business pipeline.

Beyond its immediate financial impact, the project strengthens L&T’s credentials as a global engineering and construction company. Winning a contract of this scale from a major UAE energy company demonstrates the ability of an Indian company to compete for complex projects in highly competitive international markets.

The contract is also significant for L&T Energy Hydrocarbon Offshore, which has been expanding its capabilities in offshore engineering, fabrication and construction. Projects involving both new offshore facilities and upgrades to existing assets provide the company with an opportunity to leverage its experience across different stages of the energy value chain.

For ADNOC Offshore, the project forms part of the UAE’s broader effort to strengthen and modernise its offshore energy infrastructure. For L&T, it adds another substantial international project to its pipeline and deepens its relationship with one of the region’s major energy players.

The latest order could also open the door to further opportunities in the Gulf. As ADNOC and other regional energy companies continue investing in offshore assets, companies with proven engineering, procurement and construction capabilities are likely to remain in demand.

The ₹15,000-crore-plus contract therefore represents more than a single order for L&T. It reinforces the company’s position in the Middle East, strengthens its international EPC portfolio and showcases the growing global footprint of Indian engineering expertise.

Categories
Corporate

Sensex rises 150 points, Nifty holds above 24,600

ndian benchmark indices ended Wednesday, August 5, with modest gains after a highly volatile session in which early optimism gave way to cautious trading. The BSE Sensex closed at 78,581, rising 152.05 points, or 0.19%, while the NSE Nifty50 settled at 24,624.65, up 9.75 points, or 0.04%. Both indices finished well off their day’s highs as investors booked profits and remained cautious over renewed geopolitical tensions involving the US, Iran and the Strait of Hormuz.

The session started on a much stronger note. The Sensex jumped 626 points in early trade to touch 79,055.38, while the Nifty climbed nearly 63 points to 24,677.60. The initial buying was supported by positive global cues, hopes of progress in US-Iran discussions and a decline in crude oil prices. However, the rally lost momentum as the day progressed.

For investors watching the Indian stock market, Wednesday’s trading showed how quickly sentiment can change. The market moved from a strong opening to a near-flat close, reflecting a mix of optimism over domestic growth and caution over global risks.

One of the biggest factors weighing on sentiment was fresh uncertainty around the Strait of Hormuz. US President Donald Trump said the strategic waterway would reopen “very soon” but also warned Iran of a strong military response if the blockage continued. His comments revived concerns about the possibility of further escalation in the Middle East.

The Strait of Hormuz is particularly important for global energy markets because a prolonged disruption can affect crude oil supplies and shipping costs. For India, higher crude prices can create pressure on inflation, the rupee and corporate margins. This makes developments around the waterway an important factor for Dalal Street.

Profit booking was another reason behind the market’s retreat. After the sharp gains seen in the previous sessions, investors used the morning rally to lock in profits. The Nifty also struggled to sustain levels near 24,700, which has emerged as an important resistance zone in the near term.

Technical analysts said the index remained range-bound after failing to decisively break above the 24,700 mark. The 24,500 level provided support during the session, while 24,800 remains an important hurdle. A sustained move above 24,800 could improve the short-term market outlook, while a break below 24,400 could increase selling pressure.

Among individual stocks, Shriram Finance and Grasim Industries were among the notable Nifty gainers, with both rising around 3% at different points and remaining among the stronger performers. Larsen & Toubro also gained, while several stocks saw selling pressure as investors rotated between sectors.

On the other side, ITC, HCL Technologies and Coal India were among the notable laggards, falling by up to around 1%. Their weakness limited the gains in the benchmark indices.

The broader market also remained mixed. While some large-cap stocks attracted buying interest, investors were selective rather than aggressively adding positions. The market’s behaviour suggested that traders were paying close attention to corporate earnings, global cues, crude oil prices and currency movements before making fresh bets.

The RBI’s monetary policy decision was another important event for investors. The central bank kept the repo rate unchanged at 5.25%, while its assessment of inflation and economic growth remained in focus. The decision removed an immediate source of uncertainty for rate-sensitive stocks, although it did not trigger a sustained market rally.

Global markets offered some support at the start of the session. US stocks had closed at record highs, while Asian markets opened higher amid hopes of an interim understanding between Washington and Tehran. Falling oil prices also helped improve sentiment because lower energy costs are generally positive for oil-importing economies such as India.

The rupee and foreign investor flows are also likely to remain important market drivers. A stronger domestic currency and steady foreign institutional investment could provide support to Indian equities, while renewed selling by foreign investors could add pressure.

Wednesday’s market action also came after the Nifty ended a four-session winning streak on Tuesday. The introduction of the new Closing Auction Session had contributed to unusual volatility in the previous session, making traders more cautious about interpreting sharp late-day movements.

Corporate earnings, RBI policy, crude oil prices, US-Iran developments and foreign fund flows are likely to determine the next major move.

The day’s action ultimately delivered a simple message: buyers remain present, but they are unwilling to chase the market aggressively at higher levels.